Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications that mimic the action of a naturally occurring hormone in your body
The relationship with food transforms from emotional dependence into strategic fueling supporting your ambitious lifestyle
Robert Popovian 01:54 Well, transparency is really the backbone of the healthcare system, because patients are being asked to carry more and more the burden of out of pocket costs whether it comes to hospital expenditures, their insurance premiums, their pharmaceuticals, and they need to know exactly what is it that theyre going to pay out of pocket before they walk into a pharmacy to a physicians office, for a hospital admission
Enter: GLP-1 agonists like semaglutide and liraglutide, new-ish drugs that have only recently hit the mainstream, which were originally designed to treat type 2 diabetes, but have since found favor as weight-loss wonder drugs
This could involve a mixture of lowering the dose
Rosas, P.C., Nagaraja, G.M., Kaur, P., Panossian, A., Wickman, G., Garcia, L.R., Al- Khamis, A.F., Asea, A